ILT5/CD85a/LILRB3 Antibody (4F9) - BSA Free, Novus Biologicals™

ILT5/CD85a/LILRB3

Monoclonal

1.0 mg/mL

Flow Cytometry 1:50-1:200, Immunohistochemistry 1:10-1:500, Immunohistochemistry-Frozen 1:100

Q8NHL6

LILRB3

Monocyte derived dendritic cells

0.025 mg

Primary

NB100-64329 is specific for human CD85a (leucocyte immunoglobulin-like receptor, subfamily B, member 3/ LILRB3), also known as ILT-5, expressed by monocytes, dendritic cells, macrophages, subpopulation of T lymphocytes, B cells and at high levels on plasma cells. CD85a is a 631 amino acid type I transmembrane glycoprotein, which contains four immunoreceptor tyrosine-based inhibition motif (ITIM) sequences within a long cytoplasmic tail. Phosphorylation of the tyrosine residues within ITIMs is known to enable the binding and activation of protein tyrosine phosphatases, which act as cell signalling modulators and inhibitors of cell activation.

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

IgG1

Immunohistochemistry (Frozen), Immunohistochemistry, Flow Cytometry

4F9

Unconjugated

Phosphate buffered saline with 0.09% Sodium Azide

CD85 antigen-like family member A, CD85a antigen, HL9Immunoglobulin-like transcript 5, ILT-5, ILT5CD85a, Leukocyte immunoglobulin-like receptor 3, leukocyte immunoglobulin-like receptor subfamily B member 3, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR3CD85A, LIR-3MGC138403, member 3, Monocyte inhibitory receptor HL9, PIRB

Mouse

Protein G purified

RUO

11025

Human

Purified